Helen Katherine Ellias
Board Member
SAB Biotherapeutics, Inc. (SABS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Helen Katherine Ellias
Helen Katherine Ellias is recorded as Board Member at SAB Biotherapeutics, Inc. (SABS). SAB Biotherapeutics, Inc. reported in an 8-K filed November 20, 2023 that Helen Katherine Ellias was appointed Class II director, effective November 20, 2023.
“the Board subsequently appointed, Ms. Helen Katherine Ellias to serve as a Class II director of the Company, effective as of November 20, 2023 until the Company's 2026 annual meeting of stockholders or until Ms. Ellias' successor is duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-11-20–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at SAB Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Samuel J. Reich CEO, Board Member
- David Zaccardelli Chairman, Board Member
- Lucy To CFO
- Mark Conley CFO
- Michael King CFO
- Christoph Bausch COO
- Andrew D. Moin Board Member
- Andrew Moin Board Member
- David Link Board Member
- Dr. Jay S. Skyler Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.